Feed Top Reports Pricing

⌘K

00:15:14·1320d

SECFilingvia Quantisnow

SEC Form EFFECT filed by Vectrus Inc.

ByQuantisnow·Wall Street's wire, on your screen.

VEC· Vectrus Inc.

Original source

This insight was delivered by Quantisnow - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VEC (Vectrus Inc.) and more on Quantisnow.

Quantisnowquantisnow.com

Quantisnow streams SEC filings, FDA approvals, analyst ratings, insider trades, and press releases to retail investors in real time. This insight was curated and delivered from the Quantisnow live feed.

Companies

VEC
Vectrus Inc.

Recent analyst ratings

Apr 1UpdateTruist$65.00
Mar 18UpdateStifel$42.00

Related

SEC1193d
Vectrus Inc. filed SEC Form 8-K: Shareholder Director Nominations, Other Events
INSIDER1204d
SEC Form 4: Boyington John Edward Jr. converted options into 517,918 units of V2X and covered exercise/tax liability with 200,394 units of V2X
INSIDER1204d
SEC Form 4: Mendoza Richard covered exercise/tax liability with 5,540 units of V2X and converted options into 18,207 units of V2X
INSIDER1204d
SEC Form 4: Beard William Wayne converted options into 29,315 units of V2X and covered exercise/tax liability with 10,034 units of V2X
INSIDER1255d
SEC Form 4: Noon William Boyd bought $21,140 worth of V2X (500 units at $42.28), increasing direct ownership by 10% to 5,740 units
SEC1263d
Vectrus Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
SEC1263d
SEC Form 10-Q filed by Vectrus Inc.
SEC1267d
SEC Form S-8 filed by Vectrus Inc.

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releases Analyst ratings Insider trading FDA SEC RSS feeds

Top lists

Trending By market cap Active companies Analyst upgrades Insider purchases FDA approvals SEC filings Sectors Market reports

Company

About Pricing Publish with us Contact

Legal

Terms of use Privacy policy Cookie policy

© 2026 quantisnow.com · Democratizing insights since 2022